In the mouse model used in this study, based on a genetically inducible tissue specific Kras-dependent oncogenesis, intact RIPK1/RIPK3 signaling favored the recruitment of an immunosuppressive tumor microenvironment (58). The gene discussed is RIPK3; the disease is neoplasm.